OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?
Federica Pezzuto, Véronique Hofman, Christophe Bontoux, et al.
Lung Cancer (2023) Vol. 181, pp. 107249-107249
Open Access | Times Cited: 14
Federica Pezzuto, Véronique Hofman, Christophe Bontoux, et al.
Lung Cancer (2023) Vol. 181, pp. 107249-107249
Open Access | Times Cited: 14
Showing 14 citing articles:
Non-small-cell lung cancer
Lizza E.L. Hendriks, Jordi Remón, C. Faivre‐Finn, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 43
Lizza E.L. Hendriks, Jordi Remón, C. Faivre‐Finn, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 43
Diverse clinical outcomes for the EGFR‑mutated and ALK‑rearranged advanced non‑squamous non‑small cell lung cancer
Chun-Wei Lin, Kuo‐Yang Huang, Ching‐Hsiung Lin, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Chun-Wei Lin, Kuo‐Yang Huang, Ching‐Hsiung Lin, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access | Times Cited: 1
Costs of biomarker testing in advanced non‐small cell lung cancer: a global study comparing next‐generation sequencing and single‐gene testing
Umberto Malapelle, Chien‐Chin Chen, Enrique de Álava, et al.
The Journal of Pathology Clinical Research (2025) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Umberto Malapelle, Chien‐Chin Chen, Enrique de Álava, et al.
The Journal of Pathology Clinical Research (2025) Vol. 11, Iss. 2
Open Access | Times Cited: 1
Current challenges and practical aspects of molecular pathology for non-small cell lung cancers
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 20
Paul Hofman, Sabina Berezowska, Daniel Kazdal, et al.
Virchows Archiv (2023) Vol. 484, Iss. 2, pp. 233-246
Open Access | Times Cited: 20
Effects of Tp53 Gene Mutations on the Survival of Non-Small Cell Lung Cancer (NSCLC); A Short Review
Chi Zhang, Chao Yang, Qingming Shi
Cancer Management and Research (2025) Vol. Volume 17, pp. 65-82
Open Access
Chi Zhang, Chao Yang, Qingming Shi
Cancer Management and Research (2025) Vol. Volume 17, pp. 65-82
Open Access
ALK-rearranged primary mixed mucinous and non-mucinous lung adenocarcinoma: A case report
D. González, Catalina Castañeda-Motta, Alfredo Romero-Rojas, et al.
Revista Española de Patología (2025) Vol. 58, Iss. 1, pp. 100796-100796
Closed Access
D. González, Catalina Castañeda-Motta, Alfredo Romero-Rojas, et al.
Revista Española de Patología (2025) Vol. 58, Iss. 1, pp. 100796-100796
Closed Access
Artificial intelligence for diagnosis and predictive biomarkers in Non-Small cell lung cancer Patients: New promises but also new hurdles for the pathologist
Paul Hofman, Iordanis Ourailidis, Eva Romanovsky, et al.
Lung Cancer (2025) Vol. 200, pp. 108110-108110
Closed Access
Paul Hofman, Iordanis Ourailidis, Eva Romanovsky, et al.
Lung Cancer (2025) Vol. 200, pp. 108110-108110
Closed Access
Impact and reproducibility of in-house targeted next-generation sequencing biomarker testing in non-small cell lung cancer: an Italian multi-institutional experience
Ida Rapa, Francesca Bertola, Gaia Roversi, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Ida Rapa, Francesca Bertola, Gaia Roversi, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Current status of molecular diagnostics for lung cancer
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, С. В. Орлов
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 742-765
Open Access | Times Cited: 2
Evgeny N. Imyanitov, Elena V. Preobrazhenskaya, С. В. Орлов
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 3, pp. 742-765
Open Access | Times Cited: 2
Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status
Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yoshihiko Taniguchi, Akihiro Tamiya, Mitsuo Osuga, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Liquid and Tissue Biopsies for Lung Cancer: Algorithms and Perspectives
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
Paul Hofman
Cancers (2024) Vol. 16, Iss. 19, pp. 3340-3340
Open Access | Times Cited: 1
Implementation of the clinical practice of liquid biopsies for thoracic oncology the experience of the RespirERA university hospital institute (Nice, France)
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
Paul Hofman
The Journal of Liquid Biopsy (2023) Vol. 1, pp. 100004-100004
Open Access | Times Cited: 2
Encouraging Fussy Eaters in EGFR-Mutated Lung Cancer
Steven G. Gray, Luciano Mutti, Tomer Meirson
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1125-1127
Closed Access
Steven G. Gray, Luciano Mutti, Tomer Meirson
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 8, pp. 1125-1127
Closed Access
Cancer du poumon : quel bilan de biologie moléculaire ?
Fabienne Escande, Karen Leroy, Céline Mascaux, et al.
Revue des Maladies Respiratoires Actualités (2024) Vol. 16, Iss. 2, pp. 2S42-2S48
Closed Access
Fabienne Escande, Karen Leroy, Céline Mascaux, et al.
Revue des Maladies Respiratoires Actualités (2024) Vol. 16, Iss. 2, pp. 2S42-2S48
Closed Access
